CN106804837A - Compound ganoderma lucidum health tea and preparation method thereof - Google Patents
Compound ganoderma lucidum health tea and preparation method thereof Download PDFInfo
- Publication number
- CN106804837A CN106804837A CN201610900394.5A CN201610900394A CN106804837A CN 106804837 A CN106804837 A CN 106804837A CN 201610900394 A CN201610900394 A CN 201610900394A CN 106804837 A CN106804837 A CN 106804837A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- health preserving
- preserving tea
- compound ganoderma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 25
- 230000036541 health Effects 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 240000008397 Ganoderma lucidum Species 0.000 title abstract description 34
- 235000001637 Ganoderma lucidum Nutrition 0.000 title abstract description 34
- 244000269722 Thea sinensis Species 0.000 title abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 78
- 241000233866 Fungi Species 0.000 claims abstract description 9
- 239000008681 Phellinus linteus extract Substances 0.000 claims abstract 8
- 241001149422 Ganoderma applanatum Species 0.000 claims abstract 5
- 241000222336 Ganoderma Species 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 16
- 240000000249 Morus alba Species 0.000 claims description 15
- 235000008708 Morus alba Nutrition 0.000 claims description 15
- 241000414067 Inonotus obliquus Species 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 9
- 239000011148 porous material Substances 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 230000002829 reductive effect Effects 0.000 claims description 7
- 238000011282 treatment Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 3
- 241001122767 Theaceae Species 0.000 claims 13
- 241000207961 Sesamum Species 0.000 claims 6
- 235000003434 Sesamum indicum Nutrition 0.000 claims 6
- 239000012467 final product Substances 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 230000036039 immunity Effects 0.000 abstract description 8
- 241000222355 Trametes versicolor Species 0.000 abstract description 3
- 230000002503 metabolic effect Effects 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 241000123150 Fomitopsis pinicola Species 0.000 abstract 1
- 241000747105 Fuscoporia Species 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 abstract 1
- 241000123107 Phellinus Species 0.000 description 14
- 239000000284 extract Substances 0.000 description 13
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 241000123247 Inonotus Species 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 7
- 150000004676 glycans Chemical class 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 5
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 5
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 208000006454 hepatitis Diseases 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229940116269 uric acid Drugs 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 206010008909 Chronic Hepatitis Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000003648 triterpenes Chemical class 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000283070 Equus zebra Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- JMSVCTWVEWCHDZ-UHFFFAOYSA-N syringic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1O JMSVCTWVEWCHDZ-UHFFFAOYSA-N 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241000218213 Morus <angiosperm> Species 0.000 description 1
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000222354 Trametes Species 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- -1 alkaloid compounds Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000011394 anticancer treatment Methods 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 150000002224 folic acids Chemical class 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 229940124644 immune regulator Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229920005610 lignin Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- YIBXWXOYFGZLRU-UHFFFAOYSA-N syringic aldehyde Natural products CC12CCC(C3(CCC(=O)C(C)(C)C3CC=3)C)C=3C1(C)CCC2C1COC(C)(C)C(O)C(O)C1 YIBXWXOYFGZLRU-UHFFFAOYSA-N 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 1
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域technical field
本发明属于保健食品领域,具体涉及一种复方灵芝养生茶及其制备方法。The invention belongs to the field of health food, and in particular relates to a compound ganoderma lucidum health-preserving tea and a preparation method thereof.
背景技术Background technique
现代社会的人们正受到四面八方而来的污染,有相当一部分人属于中医的“治未病”或现代医学的“亚健康”范畴,机体的自愈能力和免疫功能急速下降。身体是一个极其复杂的系统,尤以五脏六腑为主力,各司其职缺一不可,五脏其中之肝主藏血、疏泄,能调节血液流量和全身气机。而当人体活动时,机体所需血量增加,血液则会由肝脏输送到身体各经脉,以供全身各组织器官所需。肝损伤会最先直接引发血管问题和疾病,进而令各五脏六腑机体功能下降令机体陷入恶性循环,降低机体免疫力。科学研究证明人体每日大约产生10000个左右的癌细胞,正常会由人体免疫系统对付,一般人不会得癌症,但现代人类每分每秒受到四方八面的污染攻击直接降低了人体免疫系统对付癌细胞的能力,再加上适合癌细胞変异的酸性体质,就会大大提高患癌风险。People in modern society are being polluted from all directions. A considerable number of people fall into the category of "preventive treatment" of traditional Chinese medicine or "sub-health" of modern medicine, and the body's self-healing ability and immune function decline rapidly. The body is an extremely complex system, especially the five internal organs and six internal organs, each of which performs its own duties is indispensable. Among the five internal organs, the liver is responsible for storing blood, dredging, and regulating blood flow and the whole body's energy flow. When the human body is active, the amount of blood required by the body increases, and the blood will be transported from the liver to the meridians of the body to supply the needs of various tissues and organs throughout the body. Liver damage will first directly lead to vascular problems and diseases, and then reduce the function of the internal organs, causing the body to fall into a vicious circle and reduce the body's immunity. Scientific research has proved that the human body produces about 10,000 cancer cells every day, which are normally dealt with by the human immune system. Most people will not get cancer, but modern humans are attacked by pollution from all directions every minute, which directly reduces the body's immune system. The ability of cancer cells, coupled with the acidic body suitable for the variation of cancer cells, will greatly increase the risk of cancer.
现代人很少接触野生灵芝,而且被传统意识灌输观念识为灵芝属遥不可及的贵重品。在古代,灵芝生长在人迹罕见的森林深处,非常稀少,且不能人工栽培,使广大百姓对野生灵芝神奇作用的了解很少,而只能望而止步,未能有机会真实了解灵芝。寒、热、温、凉为中药的四气,寒凉属阴,温热为阳,一般按“寒则热之,热则寒之”的原则来进行身体的调理。但其实还有一种特性就是平性、居中,不寒、不热、不凉、不温,灵芝即平性,适合所有人群用于调节身体机能。。食用灵芝不仅要遵循一定的用法用量,而且需要对灵芝进行一系列加工处理,但是掌握灵芝的用法用量以及这一加工处理过程不仅需要耗费大量的时间,而且十分不便于操作,因此这给普通消费者带来很大的困扰。目前,以灵芝作为原料的保健食品大多口感不佳,而且灵芝中的有效成分大多损失严重,其药用功效及保健功效没有得到充分发挥。Modern people seldom come into contact with wild Ganoderma lucidum, and are instilled in the traditional consciousness that Ganoderma lucidum is a precious product that is out of reach. In ancient times, Ganoderma lucidum grew in the depths of the rare forest. It was very rare and could not be artificially cultivated. As a result, the general public had little understanding of the miraculous effects of wild Ganoderma lucidum. Cold, heat, warm, and cool are the four qi in traditional Chinese medicine. Cold and cool belong to yin, and warm and heat are yang. Generally, the body is regulated according to the principle of "cold causes heat, and heat causes cold". But in fact, there is another characteristic that is flat, centered, not cold, not hot, not cold, not warm, Ganoderma lucidum is flat, suitable for all people to regulate body functions. . Edible Ganoderma lucidum not only needs to follow a certain usage and dosage, but also requires a series of processing of Ganoderma lucidum, but mastering the usage and dosage of Ganoderma lucidum and this processing process not only takes a lot of time, but also is very inconvenient to operate, so it is difficult for ordinary consumers. caused great trouble. At present, most health foods that use Ganoderma lucidum as a raw material have poor taste, and most of the active ingredients in Ganoderma are seriously lost, and their medicinal and health effects have not been fully utilized.
发明内容Contents of the invention
本发明的目的在于针对现有技术的不足,提供一种采用多种菌类,能够排除体内毒素、调节代谢平衡,并具有抗自由基、抗氧化、提高机体免疫力的效果的复方灵芝养生茶。The object of the present invention is to address the deficiencies in the prior art, and provide a compound Ganoderma lucidum health tea that uses a variety of fungi, can eliminate toxins in the body, regulate metabolic balance, and has the effects of anti-free radicals, anti-oxidation, and improving the body’s immunity. .
本发明为实现上述目的采用的技术方案是:一种复方灵芝养生茶,其包括:无柄赤芝粉、平盖灵芝粉、云芝粉、桑树桑黄提取物、斑褐孔菌粉;The technical solution adopted by the present invention to achieve the above object is: a compound Ganoderma lucidum health-preserving tea, which includes: Sessile red lucidum powder, flat-covered Ganoderma lucidum powder, Yunzhi powder, Phellinus mulberry extract, Inonotus zebrascens powder;
进一步地,各组份的重量份数为:无柄赤芝粉5-15份、平盖灵芝粉5-15份、云芝粉5-15份、桑树桑黄提取物5-15份、斑褐孔菌粉5-15份;Further, the parts by weight of each component are: 5-15 parts of sessile red lucidum powder, 5-15 parts of Ganoderma lucidum powder, 5-15 parts of Yunzhi powder, 5-15 parts of Phellinus mulberry extract, 5-15 parts of pore powder;
进一步地,各组份的重量份数为:无柄赤芝粉7-10份、平盖灵芝粉7-10份、云芝粉7-10份、桑树桑黄提取物7-10份、斑褐孔菌粉7-10份;Further, the parts by weight of each component are: 7-10 parts of sessile red lucidum powder, 7-10 parts of Ganoderma lucidum powder, 7-10 parts of Yunzhi powder, 7-10 parts of Phellinus mulberry extract, 7-10 parts of pore powder;
进一步地,所述复方灵芝养生茶还包括桦褐孔菌粉;Further, the compound ganoderma lucidum health tea also includes Inonotus obliquus powder;
进一步地,所述桦褐孔菌粉按重量份数计为3-7份;Further, the Inonotus obliquus powder is 3-7 parts by weight;
进一步地,所述桦褐孔菌粉按重量份数计为4-6份;Further, the Inonotus obliquus powder is 4-6 parts by weight;
进一步地,所述无柄赤芝粉、平盖灵芝粉、云芝粉、斑褐孔菌粉、桦褐孔菌粉均为经过低温真空微波处理后进行气流粉碎破壁制得;Further, the Sessile red lucidum powder, Ganoderma lucidum powder, Yunzhi powder, Inonotus zettata powder, and Inonotus obliquus powder are all prepared by airflow crushing and wall breaking after low-temperature vacuum microwave treatment;
进一步地,所述桑树桑黄提取物为用醇回流提取、减压浓缩、干燥后得到的粉末。Further, the Morus Phellinus extract is a powder obtained after reflux extraction with alcohol, concentration under reduced pressure, and drying.
本发明还公开了上述的复方灵芝养生茶的制备方法,具体步骤如下:The present invention also discloses a preparation method of the above-mentioned compound ganoderma lucidum health-preserving tea, and the specific steps are as follows:
(1)制备制备除桑树桑黄提取物外的各原料的粉,,根据配方将上述原料混合均匀;(1) Prepare the powder of each raw material except the Phellinus mulberry extract, and mix the above-mentioned raw materials according to the formula;
(2)制备桑树桑黄提取物,并与步骤(1)得到的混合物混合均匀;(2) prepare Phellinus Phellinus extract, and mix with the mixture that step (1) obtains;
(3)将步骤(2)得到的混合物进行烘干处理和灭菌处理即得到产品;(3) Drying and sterilizing the mixture obtained in step (2) to obtain the product;
进一步地,制备无柄赤芝粉、平盖灵芝粉、云芝粉、桦褐孔菌粉、斑褐孔菌粉为经过低温真空微波处理后进行气流粉碎破壁,制备桑树桑黄提取物的方法为用醇回流提取、减压浓缩、干燥。Further, the method of preparing sessile red lucidum powder, flat-covered ganoderma lucidum powder, Yunzhi powder, Inonotus obliquus powder, and Inonotus zettata powder is to carry out airflow crushing and wall breaking after low-temperature vacuum microwave treatment, and prepare the method of Phellinus phellifolia extract Reflux extraction with alcohol, concentration under reduced pressure, and drying.
无柄赤芝,甘淡、微苦、平、无毒,能补肺益肾、和胃健脾、安神定志、扶正培本,除对癌症、脑溢血、心脏病有疗效之外。还对胃肠、肝脏、肾脏、白血病、神经衰弱、慢性支气管炎等有显著的疗效。此外还有强精、消炎、镇痛、抗菌、解毒、利尿净血等多种作用和功效,是一种历史悠久的天然免疫调节剂。Sessile red lucidum, sweet and light, slightly bitter, flat, non-toxic, can nourish the lungs and kidneys, harmonize the stomach and strengthen the spleen, soothe the nerves and calm the mind, strengthen the body and cultivate the body. In addition to being curative for cancer, cerebral hemorrhage and heart disease. It also has significant curative effects on gastrointestinal, liver, kidney, leukemia, neurasthenia, chronic bronchitis, etc. In addition, it has many functions and effects such as strengthening essence, anti-inflammatory, analgesic, antibacterial, detoxification, diuresis and blood purification, etc. It is a natural immune regulator with a long history.
平盖灵芝,微苦、平。具有增强人体免疫功能.消除疲劳.保肝护肝.抑制癌细胞生长,提高睡眠质量,排肠毒、美容,滋补强身以及止痛、清热、化积、止血、化痰,安神的功效,主治食管癌、肺癌、肝癌、鼻咽癌、胰腺癌、急慢性肝炎、早期肝硬化、神经衰弱、肠风泻血、消化不良.风湿性肺结核等,它含有丰富的麦角甾醇、灵芝酸、灵芝多糖、氨基酸、多肽、腺苷、三萜类及多种微量元素,其中有机锗含量高达12380ppm,有机硒含量也很高。两千年前的《神农本草经》把野生灵芝位列上药中之最高品目。并阐明野生灵芝可扶正固本、滋补强壮、延年益寿,且无毒副作用。明代著名医药学家李时珍的《本草纲目》也对野生灵芝有详细的记载。野生灵芝含有多种生理活性物质,能够增强人体免疫力,久食可全面提高人体的精、气、神。是老少皆宜的天然补品。食用人群:免疫力低下。便秘、失眠、降三高、急性慢肝炎均可食用。Ganoderma lucidum flat cover, slightly bitter, flat. It has the functions of enhancing human immune function, eliminating fatigue, protecting the liver, inhibiting the growth of cancer cells, improving sleep quality, detoxifying the intestines, beautifying, nourishing and strengthening the body, relieving pain, clearing away heat, dissolving accumulation, hemostasis, resolving phlegm, calming the nerves, and mainly treating the esophagus Cancer, lung cancer, liver cancer, nasopharyngeal cancer, pancreatic cancer, acute and chronic hepatitis, early liver cirrhosis, neurasthenia, intestinal wind and diarrhea, indigestion, rheumatic tuberculosis, etc. It is rich in ergosterol, ganoderma acid, ganoderma polysaccharide, Amino acids, polypeptides, adenosine, triterpenoids and various trace elements, among which the content of organic germanium is as high as 12380ppm, and the content of organic selenium is also very high. The "Shen Nong's Materia Medica" two thousand years ago listed wild Ganoderma lucidum as the highest category of medicines. It also clarifies that wild Ganoderma lucidum can strengthen the body, strengthen the body, nourish and strengthen, prolong life, and has no toxic side effects. The "Compendium of Materia Medica" written by Li Shizhen, a famous medical scientist in the Ming Dynasty, also has detailed records of wild Ganoderma lucidum. Wild Ganoderma lucidum contains a variety of physiologically active substances, which can enhance human immunity, and long-term consumption can comprehensively improve the body's essence, energy, and spirit. A natural supplement for all ages. Consumption crowd: low immunity. Constipation, insomnia, lowering the three highs, and acute and chronic hepatitis can all be eaten.
云芝,称彩云革盖菌或瓦菌,是多孔菌科植物云芝的子实体或菌丝体。云芝是一种大型珍贵药用真菌,常用于抗癌治疗。源自中国的原始森林,于中国东南西北都有分布,寄生于海拔3000米以上的阔叶树和朽木上。归经:肝;脾;肺经。功效:健脾利湿;止咳平喘;清热解毒;抗肿瘤。Versicolor versicolor, also known as Coriolus versicolor or Varrobacter, is the fruiting body or mycelium of Versicolor versicolor, a plant of Polyporaceae. Coriolus versicolor is a large and valuable medicinal fungus, which is often used in anticancer treatment. Originated from the virgin forests of China, it is distributed in the southeast and northwest of China, and parasitizes on broad-leaved trees and dead wood above 3000 meters above sea level. Channels returned: liver; spleen; lung meridian. Efficacy: invigorating the spleen and dampness; relieving cough and asthma; clearing heat and detoxifying; anti-tumor.
桑黄,味苦、性温,利五脏,软坚,排毒,止血,活血,和胃止泻。主治淋病,崩漏带下,症瘕积聚,癖饮,脾虚泄泻。能强化免疫力,促进肝细胞再生,可用于防治慢性肝炎、肝硬化、肝腹水等。能降低和调整血糖浓度,有效的预防及改善糖尿病。能够降低血脂,防止动脉硬化,防止心脑血管病的发生。桑黄提取物能够完全抑制尿酸,对痛风有良好效果。有关研究表明,桑黄及提取物对人体无毒无害,即使长期大剂量服用亦无任何毒副作用。Phellinus Phellinus, bitter in taste, warm in nature, beneficial to the five internal organs, soft and firm, detoxification, hemostasis, invigorating blood circulation, harmonizing the stomach and relieving diarrhea. Cure mainly gonorrhea, uterine bleeding, leukorrhagia, accumulation of lumps in the abdomen, addiction to drinking, diarrhea due to spleen deficiency. It can strengthen immunity, promote liver cell regeneration, and can be used to prevent and treat chronic hepatitis, cirrhosis, and ascites. Can reduce and adjust blood sugar concentration, effectively prevent and improve diabetes. It can lower blood fat, prevent arteriosclerosis, and prevent the occurrence of cardiovascular and cerebrovascular diseases. Phellinus extract can completely inhibit uric acid and has a good effect on gout. Relevant studies have shown that Phellinus Phellinus and its extracts are non-toxic and harmless to the human body, even if taken in large doses for a long time, there will be no toxic or side effects.
斑褐孔菌,味辛,性温。能活血通经,被动瘀止痛。用于心痛(心绞痛)、心律失常,以及血瘀闭经、痛经、月经不调和症瘕积聚等症。斑褐孔菌成分复杂,其发酵物中除含较多酚类物质外,还含有多糖物质。采用抗脑垂体后叶素为指标进行筛选,证明多糖为其主要活性成分。在多糖的组分中,主要是半乳糖和木糖。Inonotus zebrascens, pungent in taste, warm in nature. Can invigorate blood circulation and stimulate menstruation, relieve pain passively. It is used for heartache (angina pectoris), arrhythmia, blood stasis, amenorrhea, dysmenorrhea, irregular menstruation, and accumulation of abdominal pain. The composition of Inonotus zebrascens is complex, and its fermented product contains not only more phenolic substances, but also polysaccharides. Anti-pituitrin was used as an index to screen, and it was proved that polysaccharide was its main active ingredient. Among the components of polysaccharides, mainly galactose and xylose.
桦褐孔菌,化学成分有多糖、桦褐孔菌素、桦褐孔菌醇、多种氧化三萜类化合物、栓菌酸、多种羊毛甾醇型三萜类化合物、叶酸衍生物、芳香族的香草酸、丁香酸及γ羟基苯甲酸,还有报道称已分离出单宁化合物、类固醇、生物碱类化合物、黑色素类、低分子多酚类及木质素类化合物.桦褐孔菌含有大量的抗癌、降血压、降血糖、复活免疫作用的植物纤维类多糖体。可以提高免疫细胞的活力,抑制癌细胞扩散和复发,在胃肠内防止致癌物质等有害物质的吸收,并促进排泄。Inonotus obliquus, chemical composition polysaccharides, inonotulin, inonotol, various oxidized triterpenoids, Trametes acid, various lanosterol-type triterpenoids, folic acid derivatives, aromatic vanillic acid, syringic acid and γ-hydroxybenzoic acid, and it has been reported that tannin compounds, steroids, alkaloid compounds, melanin, low molecular polyphenols and lignin compounds have been isolated. Inonotus obliquus contains a large amount of Plant fiber polysaccharides with anti-cancer, lowering blood pressure, lowering blood sugar, and revitalizing immunity. It can improve the vitality of immune cells, inhibit the proliferation and recurrence of cancer cells, prevent the absorption of harmful substances such as carcinogens in the gastrointestinal tract, and promote excretion.
综上所述,由于采用了上述技术方案,本发明的有益效果是:In summary, owing to adopting above-mentioned technical scheme, the beneficial effect of the present invention is:
采用多种菌类,能够排除体内毒素、调节代谢平衡,并具有抗自由基、抗氧化、提高机体免疫力的效果,各组份相辅相成,达到最优的祛病延年、益寿养生的效果。Using a variety of fungi can eliminate toxins in the body, regulate metabolic balance, and have the effects of anti-free radicals, anti-oxidation, and improving the body's immunity. .
具体实施方式detailed description
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the drawings in the embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.
实施例1Example 1
一种复方灵芝养生茶,按重量份包含以下组份:A compound ganoderma lucidum health-preserving tea comprises the following components by weight:
无柄赤芝粉10份、平盖灵芝粉10份、云芝粉10份、桑树桑黄提取物7份、斑褐孔菌粉7份。Sessile red lucidum powder 10 parts, Ganoderma lucidum powder 10 parts, Yunzhi powder 10 parts, Phellinus mulberry extract 7 parts, Inonotus zebra powder 7 parts.
其制备方法包括以下步骤:Its preparation method comprises the following steps:
(1)经过低温真空微波处理后进行气流粉碎破壁制备无柄赤芝粉、平盖灵芝粉、云芝粉、斑褐孔菌粉,根据配方将上述原料混合均匀;(1) After low-temperature vacuum microwave treatment, airflow crushing and wall breaking are carried out to prepare Sessile red lucidum powder, Ganoderma lucidum powder, Yunzhi powder, and Inonotus zebrascens powder, and mix the above-mentioned raw materials evenly according to the formula;
(2)用醇浓度为80%的正丙醇回流提取2小时、减压浓缩、干燥制备桑树桑黄提取物,并与步骤(1)得到的混合物混合均匀;(2) reflux extraction with 80% n-propanol for 2 hours, concentration under reduced pressure, drying to prepare Phellinus mulberry extract, and mix evenly with the mixture obtained in step (1);
(3)将步骤(2)得到的混合物进行烘干处理和灭菌处理即得到产品。(3) drying and sterilizing the mixture obtained in step (2) to obtain the product.
实施例2Example 2
一种复方灵芝养生茶,按重量份包含以下组份:A compound ganoderma lucidum health-preserving tea comprises the following components by weight:
无柄赤芝粉10份、平盖灵芝粉10份、云芝粉10份、桑树桑黄提取物7份、斑褐孔菌粉7份、桦褐孔菌粉4份。Sessile red lucidum powder 10 parts, Ganoderma lucidum powder 10 parts, Yunzhi powder 10 parts, Phellinus mulberry extract 7 parts, Inonotus zebra powder 7 parts, Inonotus obliquus powder 4 parts.
其制备方法包括以下步骤:Its preparation method comprises the following steps:
(1)经过低温真空微波处理后进行气流粉碎破壁制备无柄赤芝粉、平盖灵芝粉、云芝粉、桦褐孔菌粉、斑褐孔菌粉,根据配方将上述原料混合均匀;(1) After low-temperature vacuum microwave treatment, carry out airflow crushing and wall breaking to prepare Sessile red lucidum powder, Ganoderma lucidum powder, Yunzhi powder, Inonotus obliquus powder, and Inonotus zebras powder, and mix the above raw materials evenly according to the formula;
(2)用醇浓度为80%的正丙醇回流提取2小时、减压浓缩、干燥制备桑树桑黄提取物,并与步骤(1)得到的混合物混合均匀;(2) reflux extraction with 80% n-propanol for 2 hours, concentration under reduced pressure, drying to prepare Phellinus mulberry extract, and mix evenly with the mixture obtained in step (1);
(3)将步骤(2)得到的混合物进行烘干处理和灭菌处理即得到产品。(3) drying and sterilizing the mixture obtained in step (2) to obtain the product.
该配方经过内部试用后,经追踪调查了解如下:After this formula is through internal trial, understands as follows through follow-up investigation:
张XX、男、37岁、工职人群,因工作压力引起头痛失眠,经服用该产品三个月后,头痛症状减轻,失眠症状明显好转。Zhang XX, male, 37 years old, workers, headache and insomnia caused by work pressure, after taking this product for three months, the headache symptoms were relieved, and the insomnia symptoms were obviously improved.
黄女士,女,30岁,家庭主妇,产后引起的过度肥胖,高血脂,脂肪肝,肠胃炎等,经服用此配方2个月,肠胃明显改善,排毒效果甚好,体重有下降。Ms. Huang, female, 30 years old, housewife, postpartum obesity, hyperlipidemia, fatty liver, gastroenteritis, etc. After taking this formula for 2 months, the stomach and intestines improved significantly, the detoxification effect is very good, and the weight has dropped.
陈XX,男,48岁,管理阶层人士,失眠体制抵抗力较低容易感冒,经服用该配方三个月后,失眠质量有所改善,感冒次数减少.体制抵抗力有所增加.Chen XX, male, 48 years old, a person in the management class, has a low resistance to insomnia and is prone to colds. After taking this formula for three months, the quality of insomnia has improved, the number of colds has decreased, and the resistance of the system has increased.
孙女士,63岁,退休职工,经常头痛头晕,经服用此配方1个多月后,头不晕不痛,已全治愈。Ms. Sun, 63 years old, a retired employee, often suffers from headache and dizziness. After taking this formula for more than a month, her head is not dizzy or painful, and has been completely cured.
黄先生,华为职工,36岁,糖尿病患者,经服用三个月后,已经停用處方药。Mr. Huang, a Huawei employee, 36 years old, a diabetic patient, has stopped taking prescription drugs after taking it for three months.
张女士,58岁,深圳南油集团退休经理,患有肿瘤,经服用此配方三个月后,肿瘤缩小,精神状态好。Ms. Zhang, 58 years old, retired manager of Shenzhen Nanyou Group, suffered from tumor. After taking this formula for three months, the tumor shrank and her mental state was good.
李先生,29岁,酒店经理,患有先天性支气管炎,偶尔头痛失眠,经服用2个月后,症状有所改善,头痛失眠大大改善。Mr. Li, 29 years old, hotel manager, suffers from congenital bronchitis, and occasionally has headache and insomnia. After taking it for 2 months, the symptoms have improved, and the headache and insomnia have been greatly improved.
霍女士,39岁,中国银行经理,月经不调,血量不足,产后更伴有妇科炎症,经服用两个月后,月经正常,炎症减少。Ms. Huo, 39 years old, manager of Bank of China, has irregular menstruation, insufficient blood volume, and gynecological inflammation after childbirth. After taking it for two months, her menstruation is normal and the inflammation is reduced.
余先生,61岁,派出所退休民警,三高人士,尿酸超标严重,经服用三个月后。尿酸症状已无再复发迹象,血脂基本回复正常指标,血压正常。身体状态好。Mr. Yu, 61 years old, a retired policeman from the police station, a member of the "Three Highs", the uric acid exceeded the standard seriously, after taking it for three months. The uric acid symptoms showed no signs of recurrence, blood lipids basically returned to normal indicators, and blood pressure was normal. Physical condition is good.
华先生,56岁,公安局局长,三高,尿酸高,失眠头痛,掉头发,经服用三个月后,尿酸状态已无复发迹象,血脂血压正常,睡眠状态良好,无头痛。Mr. Hua, 56 years old, director of the Public Security Bureau, has three highs, high uric acid, insomnia, headache, and hair loss. After taking it for three months, the uric acid state has no signs of recurrence, blood lipids and blood pressure are normal, sleep is good, and there is no headache.
上述实施例只是为了说明本发明的技术构思及特点,其目的是在于让本领域内的普通技术人员能够了解本发明的内容并据以实施,并不能以此限制本发明的保护范围。凡是根据本发明内容的实质所作出的等效的变化或修饰,都应涵盖在本发明的保护范围内。The above-mentioned embodiments are only to illustrate the technical concept and characteristics of the present invention, and its purpose is to enable those of ordinary skill in the art to understand the content of the present invention and implement it accordingly, and cannot limit the protection scope of the present invention. All equivalent changes or modifications made according to the essence of the present invention shall fall within the protection scope of the present invention.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610900394.5A CN106804837A (en) | 2016-10-14 | 2016-10-14 | Compound ganoderma lucidum health tea and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610900394.5A CN106804837A (en) | 2016-10-14 | 2016-10-14 | Compound ganoderma lucidum health tea and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106804837A true CN106804837A (en) | 2017-06-09 |
Family
ID=59106594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610900394.5A Pending CN106804837A (en) | 2016-10-14 | 2016-10-14 | Compound ganoderma lucidum health tea and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106804837A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108968031A (en) * | 2018-08-06 | 2018-12-11 | 深圳市玺越生物科技有限公司 | The antitumor row liver poison Wild ganoderma product of anticancer and technology of preparing |
| CN109852519A (en) * | 2019-03-06 | 2019-06-07 | 肖文贤 | A kind of health liquor and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5980969A (en) * | 1997-09-15 | 1999-11-09 | Lipton, Division Of Conopco, Inc. | Powdered tea concentrate, method for foaming tea concentrate and delivery system for preparing same |
| CN102429064A (en) * | 2011-11-28 | 2012-05-02 | 谭铁寒 | Compound pin leaf and ganoderma tea and making method thereof |
| CN103845369A (en) * | 2014-01-17 | 2014-06-11 | 安徽省康美来大别山生物科技有限公司 | Application of phellinus igniarius extract in preparing medicine for improving immunity |
-
2016
- 2016-10-14 CN CN201610900394.5A patent/CN106804837A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5980969A (en) * | 1997-09-15 | 1999-11-09 | Lipton, Division Of Conopco, Inc. | Powdered tea concentrate, method for foaming tea concentrate and delivery system for preparing same |
| CN102429064A (en) * | 2011-11-28 | 2012-05-02 | 谭铁寒 | Compound pin leaf and ganoderma tea and making method thereof |
| CN103845369A (en) * | 2014-01-17 | 2014-06-11 | 安徽省康美来大别山生物科技有限公司 | Application of phellinus igniarius extract in preparing medicine for improving immunity |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108968031A (en) * | 2018-08-06 | 2018-12-11 | 深圳市玺越生物科技有限公司 | The antitumor row liver poison Wild ganoderma product of anticancer and technology of preparing |
| CN109852519A (en) * | 2019-03-06 | 2019-06-07 | 肖文贤 | A kind of health liquor and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104856035A (en) | Health-care product for recuperating specific intrinsic constitution | |
| CN104920687A (en) | A kind of health-preserving jasmine black tea and processing method thereof | |
| CN103479878B (en) | Medicated tea for conditioning and treating diabetes | |
| WO2021114586A1 (en) | Immune response-improving composition, preparation method and application thereof | |
| WO2014079396A1 (en) | Oil mixture for treating acne | |
| CN105028772B (en) | Health protecting tea for blood fat reducing and preparation method thereof | |
| CN106804837A (en) | Compound ganoderma lucidum health tea and preparation method thereof | |
| CN105875929A (en) | Milletia speciosa tea bag and preparation method thereof | |
| CN105878899A (en) | Eatable drug having function of assisting treatment of gastric mucosal lesion and preparation method thereof | |
| CN104988025A (en) | Liver protecting medicinal liquor | |
| CN104983949A (en) | A traditional Chinese medicine formula for treating cancer and its preparation method | |
| CN105779232B (en) | A kind of kidney-nourishing macrobiosis health preserving wine containing Golden flower and preparation method thereof | |
| CN104352603A (en) | Anti-tumor traditional Chinese medicine capable of enhancing immunity of human body | |
| CN103461970A (en) | Fresh ginseng cordyceps military | |
| CN107823293A (en) | Treat Yao nationality medicine external pulvis of canker sore and preparation method thereof | |
| CN1284848C (en) | Dry red persimmon wine and its brewing method | |
| CN102631492B (en) | Chinese medicinal composition for improving immunity and resisting fatigue | |
| CN102048212B (en) | Liver protecting beverage and preparation method thereof | |
| CN107125751A (en) | Tortoise powder, preparation method and applications | |
| CN104789410A (en) | Honeysuckle flower wine and preparation method thereof | |
| CN111643596A (en) | A Chinese medicinal composition for treating diabetes, and its preparation method | |
| CN112175783A (en) | Cinnamon vinegar and brewing process thereof | |
| CN105494774A (en) | Medicinal tea for regulating and treating diabetes | |
| CN110959856A (en) | Low-sugar tortoise jelly and preparation method thereof | |
| CN102352292B (en) | Health-care wine containing wheat malt extract and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170609 |